​王贵强:特殊人群的乙肝治疗策略

2017-07-30 邢辰 中华医学信息导报

7月28日是“世界肝炎日”,今年我国的主题是“规范检测治疗,遏制肝炎危害”。为了进一步推动乙肝的防治进展,提高公众对乙肝的认识,我们特邀中华医学会感染病学分会主任委员、北京大学第一医院感染疾病科主任王贵强教授,就特殊人群的乙肝治疗策略进行访谈,与读者分享。

7月28日是“世界肝炎日”,今年我国的主题是“规范检测治疗,遏制肝炎危害”。为了进一步推动乙肝的防治进展,提高公众对乙肝的认识,我们特邀中华医学会感染病学分会主任委员、北京大学第一医院感染疾病科主任王贵强教授,就特殊人群的乙肝治疗策略进行访谈,与读者分享。

01.妊娠期女性

目前,妊娠女性的乙型肝炎(乙肝)治疗因为客观数据有限,因此受到广大学者的关注较多,目前基本明确的有以下几点:

(1)所有妊娠期乙肝表面抗原(HBsAg)阳性的女性均需进行监测和随访,一旦分娩或出现肝炎发作,可在权衡利弊后进行抗病毒治疗。可以使用药物是替诺福韦、替比夫定等美国食品和药物管理局认定的药物妊娠安全性分类的B类药物。由于存在长期耐药性的问题,因此要优先选择强效低耐药药物(替诺福韦)治疗妊娠期女性乙肝发作。干扰素对胎儿发育有不良影响或致畸作用,属妊娠X级药物,应禁止妊娠期女性使用,且应用者需停药半年后方可妊娠。

(2)抗病毒治疗期间意外妊娠,需根据治疗方式决定能否继续妊娠。原则上,乙肝患者在抗病毒治疗期间要进行避孕,但患者如果发生意外妊娠,则需分类考虑:①如妊娠前患者使用的治疗药物是恩替卡韦、阿德福韦酯,建议换用替诺福韦,可以考虑继续妊娠。②如患者既往使用的药物为干扰素,则建议患者终止妊娠。③如果患者应用的是替诺福韦、替比夫定或拉米夫定,可以继续妊娠。

(3)高病毒载量的妊娠期女性需进行抗病毒治疗。对于高病毒载量(乙肝病毒载量>2×106 IU/ml)的妊娠期女性,需进行密切监测和随访,建议进行抗病毒治疗以预防母婴传播。一般而言,在患者妊娠24~28周至产后1个月时,应使用替诺福韦、替比夫定或拉米夫定进行治疗,优先选择替诺福韦和替比夫定进行治疗。

目前,最新的欧洲指南建议HBVDNA>2×105IU/ml就需要抗病毒治疗以阻断母婴传播,同时增加了“HBsAg定量>4log10 IU/ml”也建议应用抗病毒治疗,将有助于进一步降低乙肝的母婴传播风险。

(4)停药后,乙肝患者可以进行母乳喂养。对于乙肝产妇的母乳喂养问题,最新的美国和欧洲指南指出,应用替诺福韦进行母婴阻断或治疗,母乳喂养不是禁忌症。所有孕产妇停用抗病毒药物均需密切监测病情进展,以防疾病变化。

(5)严格区分免疫耐受期和慢性乙肝患者。部分妊娠期女性转氨酶水平较正常值略高,但已不属于HBV的免疫耐受期。这类患者停药后复发风险高,需密切随访,或按照慢性乙肝进行抗病毒治疗。


儿童乙肝病毒感染者常处于免疫耐受期,通常不考虑抗病毒治疗。对于进展期肝病或肝硬化患儿,应及时进行抗病毒治疗,但需考虑长期治疗的安全性及耐药性问题。目前批准用于儿童患者治疗的药物包括干扰素、拉米夫定、恩替卡韦、替诺福韦等。但需要注意的是,干扰素的使用年龄为2岁以上,拉米夫定、恩替卡韦限3岁以上儿童使用,替诺福韦为12岁以上儿童使用。

03.老年人群

一般而言,老年患者与一般慢性乙肝患者治疗无异,年龄不应作为慢性乙肝抗病毒治疗的禁忌证。但鉴于老年患者常存在多病共存、脏器功能下降的情况,因此老年患者的治疗应严密监测不良反应。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-08-01 flysky120

    肝炎与妊娠

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-08-01 微笑人参

    谢谢!学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-08-01 微笑人参

    实用型

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-07-30 1e147e00m93(暂无匿称)

    已学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-07-30 mimangzhe

    刚开始接触此类患者,给了明确的治疗方法

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-07-30 1e0f8808m18(暂无匿称)

    防治乙肝,任重道远。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-07-30 hhh678

    henhao

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1635529, encodeId=e6881635529b6, content=<a href='/topic/show?id=c72e6e9866b' target=_blank style='color:#2F92EE;'>#特殊人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67986, encryptionId=c72e6e9866b, topicName=特殊人群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a3922492851, createdName=124987e8m14暂无昵称, createdTime=Mon Nov 06 08:01:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029243, encodeId=267a20292433e, content=<a href='/topic/show?id=8fa96835983' target=_blank style='color:#2F92EE;'>#王贵强#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68359, encryptionId=8fa96835983, topicName=王贵强)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4902500082, createdName=1249883fm12暂无昵称, createdTime=Mon May 07 23:01:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228789, encodeId=cacf228e8950, content=肝炎与妊娠, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Aug 01 10:29:38 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228662, encodeId=19c522866266, content=谢谢!学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:57 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228660, encodeId=21b722866029, content=实用型, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Tue Aug 01 07:12:40 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228167, encodeId=a5b722816e3b, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83561965054, createdName=1e147e00m93(暂无匿称), createdTime=Sun Jul 30 20:55:05 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228155, encodeId=d5a022815519, content=刚开始接触此类患者,给了明确的治疗方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Jul 30 19:24:58 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228122, encodeId=7c5422812250, content=防治乙肝,任重道远。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Jul 30 15:34:44 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228059, encodeId=391e22805925, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Sun Jul 30 13:16:19 CST 2017, time=2017-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=228032, encodeId=2aa7228032db, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sun Jul 30 11:19:55 CST 2017, time=2017-07-30, status=1, ipAttribution=)]
    2017-07-30 Chongyang Zhang

    签到学习了很多。

    0

相关资讯

PLoS One:来自南非的经验:对妊娠妇女产前HBV感染的快速筛查

背景和目的:目前消除HIV和梅毒的母婴传播(MTCT)受到很多关注,但是关于消除HBV的母婴传播关注度很低。在撒哈拉以南非洲地区,HBV垂直传播一直都是个重要的公共卫生问题。本研究旨在评估使用快速筛查(POC)测试筛选孕妇HBV感染情况的可行性,并进行母婴阻断的干预措施。

Gastroenterol:代谢风险因素对男性慢性乙型肝炎患者肝癌和肝病相关死亡风险的影响:一个大型的队列研究

目前我们对于HBV相关的肝癌(HCC)和肝病相关死亡的绝对风险与代谢危险因子之间的关联知之甚少。

入学入职体检不准检测乙肝 我国从法规层面消除乙肝歧视

7月25日上午,国家卫计委就“介绍病毒性肝炎防治科普等有关内容”举行例行发布会。针对乙肝歧视情况是否得到改善的问题,北京友谊医院肝病中心主任、教授,中国肝炎防治基金会副理事长贾继东表示,消除对乙肝的误解,消除公众的恐惧,是减少歧视的一大途径。据悉,乙肝和丙肝是通过血液传播、没有保护措施的性传播、母婴传播三个途径进行传播的。世界肝炎日设立的目的之一就是唤起人们对肝炎的重视。我国通过科学解释肝炎传播途

乙肝治疗:在希望和挫折中艰难前行

在中国,有接近1亿人口携带乙肝病毒(HBV),而具有明显乙肝症状的患者达到2000万左右,严重威胁着公共健康,同时也给患者的升学、求职、婚姻等方面造成了重大负面影响。由于HBV的特殊性,目前很难治愈,能做到的只是控制病毒数量,延缓肝损伤进程,虽然HBV疫苗在很多年前已被开发出来,但由于庞大的感染人口基数,在未来50年内,抗HBV的任务仍然很艰巨,新型抗HBV药物的开发仍然具有重大的社会意义和市场价

PLoS ONE:乙肝患者中,男性患严重肝脏疾病的风险高于女性!

在乙肝患者中,为什么男性患严重肝病的可能性要比女性高两倍呢,这仍然是个谜。 为了解释这两者之间的差异,人们提出了一些建议,比如饮酒、吸烟,甚至是一个人喝多少水,这都可能是原因。 但是,约翰霍普金斯大学博士后研究员、德雷克塞尔大学公共卫生学院的毕业生孙博士在她最近的研究中没有发现这方面的证据,她与该学校的合作者进行了合作。患者的性行为仍然是肝脏疾病严重程度的最佳指标。 孙医生解释说:“目前,没

贾继东:提高乙肝防治水平 还需强化基层医生培训

7月28日是世界肝炎日。我国是肝炎大国,疾病负担较重,病毒性肝炎也一直是我国重大传染病防治重点之一。目前,我国大约有九千万乙肝病毒携带者,其中约两千多万的患者没有得到有效的治疗。日前,首都医科大学附属北京友谊医院肝病中心主任贾继东教授在“人民好医生”客户端科普问诊直播中呼吁,提高我国乙肝防治水平,需要继续强化基层医生培训,改善医疗技术和规范医疗行为。政府应该增加投入,进一步完善医保政策、完善药品定